At the current stage, the precise behavior of ANP and MR-proANP in response to ARNI treatment is not known [12], and therefore, it is difficult to establish if these NPs can either mimic or even be superior to BNP/NT-proBNP assessment in patients with HF. This evidence concerns the gene NR3C2 and hydrops fetalis.